Paclitaxel from Taxus brevifolia ≥95% (HPLC), powder
: Paclitaxel was first isolated in 1971 from the Pacific yew and approved for medical use in 1993.
: P 1180 (OTTO) Paclitaxel, from Taxus brevifolia ≥95% (HPLC), powder Cas 33069-62-4 - used for studying its effect on the movement of all-trans retinoic acid (ATRA) differentiated NB4 cells. P 1180 (OTTO) Paclitaxel, from Taxus brevifolia ≥95% (HPLC), powder Cas 33069-62-4 - used as a component of the dechorionation buffer for Gryllus bimaculatus eggs.
Properties
Safety Information
Signal word Danger H
azard statements H315-H317-H318-H334-H335-H341-H361-H371
Precautionary statements P260-P280-P305 + P351 + P338-P342 + P311
RIDADR NONH for all modes of transport
WGK Germany 3
RTECS DA8340700
| Packings | Price (INR) |
|
1 mg
|
5319.00
|
|
5 mg
|
17703.00
|